Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Anyone have any thoughts.........

My viewpoint is why not submit the details to the shareholders. It's upfront, and would give a positive view of a BOD decision to the shareholders (seeing as everything about any details concerning anything is only discovered down the road in 10-Q's). It directly affects the shareholders and there shouldn't be anything secret about it IMO. They're the ones who issued the PR without details and I'm skewed?

Regards

Share
New Message
Please login to post a reply